Replies

It was not necessary to “sue the FDA”, the FDA does not have and never has had the authority to restrict any physician from prescribing any licensed medicine for any reason.

Hydroxychloroquine has been licensed since 1955. Ivermectin has been licensed since 1998.

We had hydroxychloroquine + azithromycin as our standard medical protocol for hospitalized patients with COVID from February-June 2020 (by which time it was apparent that it had no effect).

We never used ivermectin because there is no evidence of an effect in hospitalized patients.

However, had I wished to use ivermectin, the FDA would have had no authority to attempt to regulate my practice, just as they had none to regulate our use of hydroxychloroquine.

We never used ivermectin because there is no evidence of an effect in hospitalized patients.

In the case of hospitalized patients, yes, it's true. But if it's true that covid is biphasic, that in the first phase, you expect the virus to be attacking the upper airway, but in the second phase, when it's lower in the trachea, the bronchi, those cells are more vulnerable, then ivermectin would be insufficient. That would be the development that would call for bigger guns - large doses of anti-inflammatories, anticoagulants, antihistamines. The right medications have to be used at the right times. I've been taking 3mg. ivermectin (with 15mg. Zn gluconate every alternate day and 2000iu vit. D daily) prophylactically since Oct. 2020. If I had the slightest notion that I were coming down with something, I would immediately titrate up to 6mg. And let me tell you, it was hard to acquire. I only take it Oct. through March. If the supply were not so precarious, I would probably take it year round.

Hydroxychloroquine, a zinc ionophore, has little value after viral replication has already taken place for patients who was admitted to hospital only after they were already having trouble breathing.